Eric Hedrick is a seasoned biotechnology executive with a strong background in oncology and hematology. With a medical degree from the University of Maryland School of Medicine, they began their career as an attending physician at Memorial Sloan-Kettering Cancer Center before holding various leadership positions at Genentech and Epizyme. Eric served as the Chief Executive Physician at EQRx, where they focused on innovative approaches to drug development and accessibility. Currently, they are the Head of Oncology Evaluation at Galapagos and work as an independent development consultant, continuing their commitment to improving patient outcomes in oncology through sustainable practices.
This person is not in the org chart
This person is not in any teams
This person is not in any offices